Shares (In millions) | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Life | Aggregate Intrinsic Value (In millions) | |||||||||
Outstanding on January 1, 2013 | 309 | $ | 27.27 | |||||||||
Granted | 56 | 37.68 | ||||||||||
Exercised | (53 | ) | 25.02 | |||||||||
Forfeited/expired | (7 | ) | 34.34 | |||||||||
Outstanding on December 31, 20131 | 305 | $ | 29.42 | 5.82 years | $ | 3,636 | ||||||
Expected to vest at December 31, 2013 | 302 | $ | 29.33 | 5.78 years | $ | 3,614 | ||||||
Exercisable on December 31, 2013 | 187 | $ | 25.87 | 4.25 years | $ | 2,887 | ||||||
1 | Includes 3 million stock option replacement awards in connection with our acquisition of CCE's former North America business in 2010. These options had a weighted-average exercise price of $18.02, and generally vest over 3 years and expire 10 years from the original date of grant. |